Dominant-Negative TGF-β Receptor Enhances PSMA-Targeted Human CAR T Cell Proliferation And Augments Prostate Cancer Eradication

Christopher C. Kloss, Ji‐Hyun Lee, Aaron Zhang, +7

Molecular Therapy

PTBP3-Mediated Regulation of ZEB1 mRNA Stability Promotes Epithelial–Mesenchymal Transition in Breast Cancer

Pingfu Hou, Lin Li, Fang Chen, +5

Cancer Research

Cardioprotective Role of Myeloid-Derived Suppressor Cells in Heart Failure

Ling Zhou, Kun Miao, Bingjiao Yin, +10

Circulation

Characterization and comparison of commercially available TNF receptor 2-Fc fusion protein products

Qingqiao Tan, Qingcheng Guo, Fang Chen, +5

mAbs

ImmunologyGlycobiologyImmunotherapyBiosimilar 2Protein Expression +22

Functional convergence of a germline-encoded neutralizing antibody response in rhesus macaques immunized with HCV envelope glycoproteins

Fang Chen, N. Tzarum, Xiaohe Lin, +17

Immunity

VaccinationFunctional ConvergenceRhesus MacaquesVaccine TargetImmunology +5

A bispecific antibody effectively inhibits tumor growth and metastasis by simultaneous blocking vascular endothelial growth factor A and osteopontin

Geng Kou, Jingping Shi, Lin Chen, +10

Cancer Letters

Tumor BiologySclerostinBone Morphogenic ProteinBispecific AntibodyTumor Growth +7

Downregulation of VMP1 confers aggressive properties to colorectal cancer

Xianzhi Guo, Xiaolei Ye, Weizhong Xiao, +8

Oncology Reports

Cancer testis antigen OY-TES-1 expression and serum immunogenicity in colorectal cancer: its relationship to clinicopathological parameters.

Bin Luo, Yun Xiang, Rong Fan, +7

PubMed

Serum ImmunogenicityTumor BiologyCancer ImmunosurveillanceMedicineImmunology +10

Identification of HCC-22-5 tumor-associated antigen and antibody response in patients

Sufang Zhou, Xiaoxun Xie, Yehong Bin, +3

Clinica Chimica Acta

Tumor ImmunologyCancer ImmunosurveillanceMedicineImmunologyTumor Immunity +6

The efficacy and safety of pyrotinib in treating HER2‐positive breast cancer patients with brain metastasis: A multicenter study

Min Gao, Chao Fu, Shanshan Li, +3

Cancer Medicine